The Cardioprotective Role of Probucol Against Anthracycline and Trastuzumab-Mediated Cardiotoxicity
- 1 June 2011
- journal article
- Published by Elsevier in Journal of the American Society of Echocardiography
- Vol. 24 (6) , 699-705
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Utility of Tissue Doppler and Strain Rate Imaging in the Early Detection of Trastuzumab and Anthracycline Mediated CardiomyopathyJournal of the American Society of Echocardiography, 2009
- Blockade of the erbB2 Receptor Induces Cardiomyocyte Death through Mitochondrial and Reactive Oxygen Species-dependent PathwaysJournal of Biological Chemistry, 2009
- Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective studyBreast Cancer Research and Treatment, 2008
- Cardiotoxicity Profile of TrastuzumabDrug Safety, 2008
- Long-Term Cardiac Tolerability of Trastuzumab in Metastatic Breast Cancer: The M.D. Anderson Cancer Center ExperienceJournal of Clinical Oncology, 2006
- Spotlight on Trastuzumab in the management of HER2-positive metastatic and early-stage breast cancer.BioDrugs, 2006
- TrastuzumabDrugs, 2006
- Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast CancerNew England Journal of Medicine, 2005
- Clinical Cardiac Tolerability of TrastuzumabJournal of Clinical Oncology, 2004